WEST PHARM.SVCS DL-,25/ US9553061055 /
| 14/11/2024 08:01:26 | Chg. -0.70 | Volume | Bid10:15:19 | Ask10:15:19 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 323.20EUR | -0.22% | 0 Turnover: 0.00 |
326.30Bid Size: 16 | 331.20Ask Size: 16 | 23.59 bill.EUR | - | - |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 855 | 822 | 839.3000 | 943.2000 | 1,057.5000 | ||||||
| Intangible Assets | 21.7000 | 20.3000 | 29.8000 | 30.5000 | 23 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 1,119.3000 | 1,084.5000 | 1,282.7000 | 1,420.1000 | 1,571.8000 | ||||||
| Inventories | 215.2000 | 214.5000 | 235.7000 | 321.3000 | 378.4000 | ||||||
| Accounts Receivable | 253.2000 | 288.2000 | 319.3000 | 385.3000 | 489 | ||||||
| Cash and Cash Equivalents | 235.9000 | 337.4000 | 439.1000 | 615.5000 | 762.6000 | ||||||
| Current Assets | 743.5000 | 894.4000 | 1,058.7000 | 1,373.7000 | 1,742 | ||||||
| Total Assets | 1,862.8000 | 1,978.9000 | 2,341.4000 | 2,793.8000 | 3,313.8000 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 138.1000 | 130.4000 | 156.8000 | 213.1000 | 232.2000 | ||||||
| Long-term debt | 197 | 196 | 255 | 252.9000 | 208.8000 | ||||||
| Liabilities to Banks | 0.0000 | .1000 | 2.3000 | - | - | ||||||
| Provisions | 16.4000 | 22.9000 | 21.9000 | - | - | ||||||
| Liabilities | 582.9000 | 582.6000 | 768.2000 | 939.3000 | 978.4000 | ||||||
| Share Capital | 18.8000 | 18.8000 | 18.8000 | 18.8000 | 18.8000 | ||||||
| Total Equity | 1,279.9000 | 1,396.3000 | 1,573.2000 | 1,854.5000 | 2,335.4000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,862.8000 | 1,978.9000 | 2,341.4000 | 2,793.8000 | 3,313.8000 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,599.1000 | 1,717.4000 | 1,839.9000 | 2,146.9000 | 2,831.6000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 228.9000 | 240.3000 | 296.6000 | 406.9000 | 752.3000 | ||||||
| Interest Income | 7.8000 | 8.4000 | 8.5000 | 8.2000 | 8.2000 | ||||||
| Income Before Taxes | 222.4000 | 240.7000 | 291.8000 | 401.3000 | 748.9000 | ||||||
| Income Taxes | 80.9000 | 41.4000 | 59 | 72.5000 | 107.2000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 150.7000 | 206.9000 | 241.7000 | 346.2000 | 661.8000 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 263.3000 | 288.6000 | 367.2000 | 472.5000 | 584 | ||||||
| Cash Flow from Investing Activities | -133.6000 | -100.8000 | -228 | -179.5000 | -253.1000 | ||||||
| Cash Flow from Financing | -109 | -80.7000 | -36.8000 | -137.1000 | -168.1000 | ||||||
| Decrease / Increase in Cash | 32.9000 | 101.5000 | 101.7000 | 176.4000 | 147.1000 | ||||||
| Employees | 7,500 | 7,700 | 8,200 | - | - | ||||||
